OTCMKTS:AKRXQ Akorn (AKRXQ) Stock Price, News & Analysis $0.03 0.00 (0.00%) As of 12/17/2020 Add Compare Share Share Stock Analysis Stock Analysis About Akorn Stock (OTCMKTS:AKRXQ) Get Akorn alerts:Sign Up Key Stats Today's Range$0.03▼$0.0350-Day Range$0.03▼$0.0352-Week Range$0.01▼$5.40VolumeN/AAverage Volume7.44 million shsMarket Capitalization$3.60 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Akorn, Inc. was a specialty pharmaceutical company focused on developing, manufacturing and marketing prescription and over-the-counter medicines. Its product portfolio historically included generic and branded pharmaceuticals, with an emphasis on ophthalmic products, injectable medicines, oral liquids and other specialized dosage forms. The company served hospitals, physicians, pharmacies, wholesalers and other health care providers, primarily in the United States. Akorn operated manufacturing and research facilities in the U.S. and had also maintained international operations and commercial relationships. Akorn experienced significant financial and operational difficulties in the late 2010s and early 2020s. It entered bankruptcy proceedings and its business was subsequently restructured and sold. The company’s common stock trades over the counter under the symbol AKRXQ, and publicly available information about its current operations and leadership is limited.AI Generated. May Contain Errors. Read More Receive AKRXQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Akorn and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AKRXQ Stock News HeadlinesAkorn Stock Price Today | OTC: AKRXQ Live - Investing.comJune 28, 2025 | investing.comBest Kamado Grill for 2024May 9, 2024 | cnet.comYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.October 16 at 1:00 AM | Profits Run (Ad)Akorn voluntarily recalls 70 human and animal drugs following bankruptcy and shutdownMay 1, 2023 | msn.comDrugmaker Akorn recalls all of its products after bankruptcyMay 1, 2023 | msn.comAkorn Issues Voluntary Nationwide Recall of Various Human and Animal Drug Products Within Expiry Due to Company ShutdownApril 26, 2023 | finance.yahoo.comAkorn (AKRX) Stock Drops Despite Q2 BeatApril 20, 2023 | thestreet.comREAD: Budzinski's letter to Akorn CEOMarch 3, 2023 | msn.comSee More Headlines AKRXQ Stock Analysis - Frequently Asked Questions How have AKRXQ shares performed this year? Akorn's stock was trading at $0.0270 at the beginning of 2026. Since then, AKRXQ shares have increased by 0.0% and is now trading at $0.0270. Company Calendar Today10/16/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:AKRXQ CIKN/A Webwww.akorn.com Phone847-279-6100Fax800-943-3694Employees2,191Year Founded1948Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$682.43 million Price / Sales0.01 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares133,451,000Free Float128,246,000Market Cap$3.60 million OptionableNot Optionable BetaN/A Social Links 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report This page (OTCMKTS:AKRXQ) was last updated on 12/17/2020 by MarketBeat.com Staff. From Our PartnersElon Musk’s 4th Wealth Window Set to Open by October 30Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He po...Brownstone Research | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredSpaceX minted 4400 millionaires in a single daySpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...Behind the Markets | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akorn, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akorn With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.